Journal of Molecular Medicine

, Volume 83, Issue 10, pp 806–811 | Cite as

Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis

  • Susanne Vogler
  • René Goedde
  • Bianca Miterski
  • Ralf Gold
  • Antje Kroner
  • Dirk Koczan
  • Uwe-Klaus Zettl
  • Peter Rieckmann
  • Joerg T. Epplen
  • Saleh M. Ibrahim
Original Article


Uncoupling protein 2 (UCP2) is a member of the mitochondrial proton transport family that uncouples proton entry to the mitochondria from ATP synthesis. UCP2 expression levels have been linked to predisposition to diabetes and obesity. In addition, UCP2 prevents neuronal death and injury. Here we show that the common −866G/A promoter polymorphism is associated with susceptibility to multiple sclerosis (MS) in the German population. We analysed altogether 1,097 MS patients and 462 control subjects from two cohorts and found that the common G allele is associated with disease susceptibility (p=0.0015). The UCP2 −866G allele is correlated with lower levels of UCP2 expression as shown here in vitro and in vivo. Thus, UCP2 promoter polymorphism may contribute to MS susceptibility by regulating the level of UCP2 protein in the central nervous and/or the immune systems.


Multiple sclerosis Uncoupling protein 2 Autoimmunity Susceptibility genes Experimental autoimmune encephalomyelitis 



We would like to thank Rica Waterstradt, Ildikó Tóth and Andrea Petzold for excellent technical assistance. This study was funded in part by the German Federal Ministry of Research and Education (FKZ 01ZZ0108) and by Hertie Stiftung (1.319.110/02/05).


  1. 1.
    Hohlfeld R, Wekerle H (2001) Immunological update on multiple sclerosis. Curr Opin Neurol 14:299–304Google Scholar
  2. 2.
    Ebers GC, Sadovnick AD, Risch NJ (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377:150–151Google Scholar
  3. 3.
    Miterski B, Jaeckel S, Epplen JT, Pohlau D, Hardt C (1999) The interferon gene cluster: a candidate region for MS predisposition? Multiple Sclerosis Study Group. Genes Immun 1:37–44Google Scholar
  4. 4.
    Epplen C, Jackel S, Santos EJ et al (1997) Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol 41:341–352Google Scholar
  5. 5.
    Sawcer S, Jones HB, Feakes R et al (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13:464–468Google Scholar
  6. 6.
    Haines JL, Ter-Minassian M, Bazyk A et al (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 13:469–471Google Scholar
  7. 7.
    Ebers GC, Kukay K, Bulman DE et al (1996) A full genome search in multiple sclerosis. Nat Genet 13:472–476Google Scholar
  8. 8.
    Kuokkanen S, Gschwend M, Rioux JD et al (1997) Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 61:1379–1387Google Scholar
  9. 9.
    Merriman TR, Cordell HJ, Eaves IA et al (2001) Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes 50:184–194Google Scholar
  10. 10.
    Butterfield RJ, Blankenhorn EP, Roper RJ, Zachary JF, Doerge RW, Teuscher C (2000) Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol 157:637–645Google Scholar
  11. 11.
    Bergsteinsdottir K, Yang HT, Pettersson U, Holmdahl R (2000) Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J Immunol 164:1564–1568Google Scholar
  12. 12.
    Ibrahim SM, Mix E, Bottcher T et al (2001) Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain 124:1927–1938Google Scholar
  13. 13.
    Baker D, Rosenwasser OA, O’Neill JK, Turk JL (1995) Genetic analysis of experimental allergic encephalomyelitis in mice. J Immunol 155:4046–4051Google Scholar
  14. 14.
    Butterfield RJ, Blankenhorn EP, Roper RJ et al (1999) Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. J Immunol 162:3096–3102Google Scholar
  15. 15.
    Schrauwen P, Hesselink M (2002) UCP2 and UCP3 in muscle controlling body metabolism. J Exp Biol 205:2275–2285Google Scholar
  16. 16.
    Arsenijevic D, Onuma H, Pecqueur C et al (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26:435–439Google Scholar
  17. 17.
    Kizaki T, Suzuki K, Hitomi Y et al (2002) Uncoupling protein 2 plays an important role in nitric oxide production of lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci U S A 99:9392–9397Google Scholar
  18. 18.
    Sullivan PG, Dube C, Dorenbos K, Steward O, Baram TZ (2003) Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann Neurol 53:711–717Google Scholar
  19. 19.
    Esterbauer H, Schneitler C, Oberkofler H et al (2001) A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28:178–183Google Scholar
  20. 20.
    Giri S, Nath N, Smith B, Viollet B, Singh AK, Singh I (2004) 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J Neurosci 24:479–487Google Scholar
  21. 21.
    Sasahara M, Nishi M, Kawashima H et al (2004) Uncoupling protein 2 promoter polymorphism −866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients. Diabetes 53:482–485Google Scholar
  22. 22.
    Poser CM, Paty DW, Scheinberg L et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231Google Scholar
  23. 23.
    Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215Google Scholar
  24. 24.
    Schneider U, Schwenk HU, Bornkamm G (1977) Characterization of EBV-genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 19:621–626Google Scholar
  25. 25.
    Sundstrom C, Nilsson K (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17:565–577Google Scholar
  26. 26.
    Fleury C, Neverova M, Collins S et al (1997) Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269–272Google Scholar
  27. 27.
    Mattiasson G, Shamloo M, Gido G, Mathi K, Tomasevic G, Yi S, Warden CH, Castilho RF, Melcher T, Gonzalez-Zulueta M, Nikolich K, Wieloch T (2003) Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med 9:1062–1068 (published online)Google Scholar
  28. 28.
    Horvath TL, Diano S, Barnstable C (2003) Mitochondrial uncoupling protein 2 in the central nervous system: neuromodulator and neuro. Biochem Pharmacol 65:1917–1921Google Scholar
  29. 29.
    Argiles JM, Busquets S, Lopez-Soriano FJ (2002) The role of uncoupling proteins in pathophysiological states. Biochem Biophys Res Commun 293:1145–1152Google Scholar
  30. 30.
    Offen D, Gilgun-Sherki Y, Barhum Y et al (2004) A low molecular weight copper chelator crosses the blood–brain barrier and attenuates experimental autoimmune encephalomyelitis. J Neurochem 89:1241–1251Google Scholar
  31. 31.
    van der Goes A, Brouwer J, Hoekstra K, Roos D, van den Berg TK, Dijkstra CD (1998) Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J Neuroimmunol 92:67–75Google Scholar
  32. 32.
    Van der Goes A, Wouters D, Van Der Pol SM et al (2001) Reactive oxygen species enhance the migration of monocytes across the blood–brain barrier in vitro. FASEB J 15:1852–1854Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Susanne Vogler
    • 1
  • René Goedde
    • 2
  • Bianca Miterski
    • 2
  • Ralf Gold
    • 3
  • Antje Kroner
    • 4
  • Dirk Koczan
    • 1
  • Uwe-Klaus Zettl
    • 5
  • Peter Rieckmann
    • 4
  • Joerg T. Epplen
    • 2
  • Saleh M. Ibrahim
    • 1
    • 6
  1. 1.Department of ImmunologyUniversity of RostockRostockGermany
  2. 2.Department of Human GeneticsRuhr UniversityBochumGermany
  3. 3.Institute of Multiple Sclerosis ResearchGeorg-August UniversityGöttingenGermany
  4. 4.Department of NeurologyUniversity of WürzburgWürzburgGermany
  5. 5.Department of NeurologyUniversity of RostockRostockGermany
  6. 6.Institute of ImmunologyUniversity of RostockRostockGermany

Personalised recommendations